About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
SOHO 2021 Next Questions in AML
By
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
FEATURING
Hagop Kantarjian
By
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
FEATURING
Hagop Kantarjian
18 views
October 1, 2021
0 Comments
Login to view comments.
Click here to Login
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Related Content
AUTOPLAY
ON
08:18
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Treatment Strategies for Hematocrit Control…
Feat.
A. Zhou
09:27
ASH 2022 Conference Coverage
MAJIC-PV Trial: Ruxolitinib vs. Best Available Therapy for PV Intole…
Feat.
M. McMullin
16:25
Northwestern Medicine Oncology and Hematology
Diagnosis and Goals of Therapy in PV
Feat.
B. Stein
51:20
Jerry Spivak
Polycythemia Vera: Disease Overview, Treatment Landscape, and Curren…
10:49
Monia Marchetti
Using Cytoreductive Therapy to Prevent Cardiovascular Events in Pati…
13:04
Winship Cancer Institute - Emory University
Treatment-Related Quality of Life in MF
Feat.
A. Hunter
13:04
Alexander Coltoff
Symptomatic Profiles of Patients With Polycythemia Vera: Implication…
37:12
Tisch Cancer Institute at Mount Sinai
Leukemia Tumor Board at the Tisch Cancer Institute at Mount Sinai: 6…
Feat.
M. Metzger
10:44
Aaron Gerds
A Real-World Evaluation of the Association Between Elevated Blood Co…
10:27
Richard T. Silver
Splenomegaly in Polycythemia Vera: Clinical Significance and Relatio…
16:18
Masterclasses in Dermatology
Masterclasses from the Wards
Feat.
S. Elman
40:05
Tisch Cancer Institute at Mount Sinai
Leukemia Tumor Board at the Tisch Cancer Institute at Mount Sinai: M…
Feat.
D. Tremblay,
J. Mascarenhas,
R. Sheppard,
A. Shih,
I. Sarami
25:01
Indy Hematology Review
Review of Emerging Therapies and Top Trials in Hematologic Malignanc…
Feat.
R. Birhiray
20:32
XIth Eurasian Hematology-Oncology Congress - EHOC 2020
Malignancy Associated Hemophagocytic Lymphohistiocytosis: Diagnosis …
Feat.
S. Kalayoglu Besisik
09:23
ASH Review VIRTUAL 2020: Current Updates in Hematologic Diseases
ASH Update on HCT for AML: Are We Starting to Refer AML Patients Ear…
Feat.
M. Mushtaq
08:04
2nd SOHO Italian Conference
Cell Morphology in Acute Leukemias & Hematologic Malignancies: D…
Feat.
G. Zini
19:10
Indy Hematology Review
Allo HSCT: Improvements in Transplant Outcomes, Myeloablative Vs. Re…
Feat.
R. Childs
10:05
KU ASH 2019 Review: Current Updates in Hematologic Diseases
ASH 2019 Update: CC-486 Demonstrated Improvement in OS and RFS in Ma…
Feat.
H. Male
11:18
Indy Hematology Review
Relapse After Allo HSCT - Treatment Strategies and Overview of Relat…
Feat.
R. Childs
25:56
UChicago Annual Updates from ASH 2019
Inherited Predisposition to Myeloid Hematologic Malignancies: Why Do…
Feat.
S. Feurstein